New Clinical Trial Opportunity

Posted on: Tuesday 5th November 2024

Recruitment has opened for a new study investigating whether a medicine, (BI 1819479), can improve lung function and quality of life for people with idiopathic pulmonary fibrosis.

  • Study locations across NSW, VIC, ACT, TAS and New Zealand
  • Participants need to be aged 40 years or older.
  • The study compares 3 different doses of BI 1819479 with a placebo.
  • Treatment will last between 6 and 12 months.

Participants will be randomised to determine if they receive a low, medium, or high dose – or placebo.

Learn more about the BI 1819479 Study and other open trials on the PACT website Find a Trial page.